loading page

Could Guillain-Barré syndrome be triggered by COVID-19 vaccination?
  • +1
  • Maya Aldeeb,
  • Lina Okar,
  • Safa Mahmud,
  • Gholam Adeli
Maya Aldeeb
Hamad Medical Corporation Medical Research Center
Author Profile
Lina Okar
Hamad Medical Corporation
Author Profile
Safa Mahmud
Hamad Medical Corporation
Author Profile
Gholam Adeli
Hamad Medical Corporation
Author Profile

Abstract

We are reporting a case of Guillain- Barré syndrome seven days after the first dose of Pfizer-BioNTech COVID-19 Vaccine. As this vaccine is still under investigation, reporting possible rare side effects is essential. In this case, the temporal relationship was suggestive of a vaccine-induced cause.

Peer review status:IN REVISION

25 Apr 2021Submitted to Clinical Case Reports
26 Apr 2021Submission Checks Completed
26 Apr 2021Assigned to Editor
04 Jul 2021Reviewer(s) Assigned
29 Jul 2021Review(s) Completed, Editorial Evaluation Pending
14 Aug 2021Editorial Decision: Revise Minor
06 Sep 20211st Revision Received
07 Sep 2021Submission Checks Completed
07 Sep 2021Assigned to Editor
07 Sep 2021Review(s) Completed, Editorial Evaluation Pending
09 Sep 2021Reviewer(s) Assigned
15 Sep 2021Editorial Decision: Revise Minor